Banner Publications MH200828 N141

Publications

Results found: 137

Showing results: 1 - 50

Cell

Identifying Epistasis in Cancer Genomes: A Delicate Affair.

30-05-2019
Key
Cell reports. Medicine

RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells.

21-06-2022
European journal of cancer (Oxford, England : 1990)

Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer.

15-06-2022
Cancer discovery

Can Drug Repurposing Accelerate Precision Oncology?

01-06-2022
Cancer chemotherapy and pharmacology

Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature.

22-05-2022
Nature cancer

Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

01-05-2022
The Lancet. Oncology

The DRUG Access Protocol: access inequality and European harmonisation - Authors' reply.

01-05-2022
Nature medicine

Delivering precision oncology to patients with cancer.

01-04-2022
Clinical cancer research : an official journal of the American Association for Cancer Research

Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment.

01-04-2022
Clinical cancer research : an official journal of the American Association for Cancer Research

Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments.

01-03-2022
Nature cancer

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

01-02-2022
The Lancet. Oncology

Harmonising patient-access programmes: the Dutch DRUG Access Protocol platform.

01-02-2022
Cancers

Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients.

16-01-2022
Frontiers in medicine

Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders.

28-12-2021
Clinical cancer research : an official journal of the American Association for Cancer Research

Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types.

15-11-2021
Molecular oncology

The Porto European Cancer Research Summit 2021.

01-10-2021
Cancer cell

Tumor organoids: Opportunities and challenges to guide precision medicine.

13-09-2021
Nature medicine

Limited evolution of the actionable metastatic cancer genome under therapeutic pressure.

01-09-2021
Cancer cell

Developing and validating model systems for immuno-oncology.

09-08-2021
Cancer discovery

Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy.

01-08-2021
ESMO open

Prospective experimental treatment of colorectal cancer patients based on organoid drug responses.

01-06-2021
Frontiers in endocrinology

Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma.

30-03-2021
BMC medical genomics

Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE).

10-11-2020
Clinical and translational radiation oncology

Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system.

01-09-2020
Molecular oncology

Towards a cancer mission in Horizon Europe: recommendations.

01-08-2020
Nature medicine

Author Correction: Caring for patients with cancer in the COVID-19 era.

01-07-2020
Nature medicine

Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal.

01-07-2020
Learning health systems

Learning health care systems: Highly needed but challenging.

01-07-2020
Nature communications

Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours.

22-06-2020
Nature communications

Partner independent fusion gene detection by multiplexed CRISPR-Cas9 enrichment and long read nanopore sequencing.

05-06-2020
European journal of cancer (Oxford, England : 1990)

Patients with cancer in the era of 2019 novel coronavirus disease.

01-06-2020
Cell reports

Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine.

05-05-2020
Nature medicine

Caring for patients with cancer in the COVID-19 era.

01-05-2020
Nature medicine

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.

01-04-2020
Molecular cancer research : MCR

Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity.

01-04-2020
ESMO open

Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancer.

01-04-2020
The Journal of pathology

BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers.

01-02-2020
Nature protocols

Tumor organoid-T-cell coculture systems.

01-01-2020
Nature communications

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact.

20-11-2019
Nature

Pan-cancer whole-genome analyses of metastatic solid tumours.

01-11-2019
Science translational medicine

Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients.

09-10-2019
Nature genetics

The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies.

01-10-2019
Annals of oncology : official journal of the European Society for Medical Oncology

When is off-label off-road?

01-10-2019
Nature

The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs.

01-10-2019
Endocrine-related cancer

The molecular genetic make-up of male breast cancer.

01-10-2019
British journal of cancer

Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations.

01-07-2019
ESMO open

Advancing molecular tumour boards: highly needed to maximise the impact of precision medicine.

25-06-2019
European journal of cancer (Oxford, England : 1990)

Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology.

01-06-2019
Annals of oncology : official journal of the European Society for Medical Oncology

Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients.

01-05-2019
Molecular oncology

Cancer Core Europe: A translational research infrastructure for a European mission on cancer.

01-03-2019

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.